Tingson, Cherame P.

HRN: 21-82-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
CEFUROXIME 500MG (TAB)
08/25/2022
09/01/2022
PO
500mg
Q12
Post Op Prophylaxis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Duration  Wrong Duration

Overall appropriateness: No  Wrong Duration

Intervention



Type of Intervention done:

                    

           


Acceptance: